Metformin boosts an exercise-linked metabolite and may help control weight in prostate cancer patients
A clinical study suggests metformin may reproduce part of exercise’s metabolic signature in prostate cancer patients, raising Lac-Phe levels while supporting better weight control during hormone treatment. Study: The anti-obesogenic metabolite, Lac-Phe, is …